Why the study?
How should resistant hypertension be defined based on blood pressure response to a triple drug regimen?
How should resistant hypertension be defined based on blood pressure response to a triple drug regimen?
This paper proposes a standardized clinical definition for resistant hypertension based on pretreatment blood pressure and response to a triple-drug regimen.
Supports standardized resistant hypertension classification; leaves open prospective validation before clinical adoption.
The following definition of resistant hypertension is proposed: Provided that adherence to the regimen can be assured, hypertension should be considered resistant if the blood pressure cannot be reduced to less than 150/100 mm Hg by a rational triple drug regimen, including a diuretic, prescribed in nearly maximal doses and if the pretreatment blood pressure was greater than or equal to 180/115 mm Hg. If the pretreatment blood pressure was less than 180/115 mm Hg, resistance should be defined as failure to achieve normotension (less than 140/90 mm Hg) on a rational triple drug regimen in nearly maximal doses.
No takes yet. Share an insight, caveat, or question.
Ray W. Gifford (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: